Can a blood pressure drug re-energize Parkinson's patients?
NCT ID NCT07464028
First seen Mar 30, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study tests whether terazosin, a drug currently used for high blood pressure, can improve energy metabolism in people with Parkinson's disease. Researchers will measure changes in a key energy molecule (ATP) in the blood of 120 participants over 6 weeks and 1.5 years. The goal is to see if the drug can help slow or manage Parkinson's symptoms by boosting cellular energy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.